J3410 HCPCS code: Injection, hydroxyzine hcl, up to 25 mg
J3410 is the HCPCS Level II code for injection, hydroxyzine hcl, up to 25 mg. In 2024 Medicare paid an average of $8.78 per service for J3410 across 691 services. Its Medicare coverage code is D (Special coverage instructions apply): Medicare covers it when its national or local coverage criteria are met. The NCCI unit limit is 16 per day on outpatient hospital claims. Medicare volume fell 47% from 2022 to 2024 (1,307 to 691 services). In 2024, about 130 clinicians billed Medicare for J3410 for 261 beneficiaries.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | D — Special coverage instructions apply |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 1982-01-01 |
| Last action effective | 1997-01-01 |
Who bills J3410 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 130 |
| Medicare beneficiaries | 261 |
| States with claims | 4 |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J3410, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 1,307 | 563 | $9.50 | $7.16 |
| 2023 | 1,156 | 462 | $11.55 | $8.72 |
| 2024 | 691 | 261 | $11.81 | $8.78 |
States with the most J3410 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| California | 241 | $8.71 |
| Louisiana | 37 | $8.44 |
| Mississippi | 26 | $7.39 |
| Minnesota | 23 | $8.38 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 16 | Prescribing Information |
| practitioner claims | 8 | Prescribing Information |
What changed for J3410
- 1982-01-01: J3410 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J3410?
J3410 is the HCPCS Level II code for injection, hydroxyzine hcl, up to 25 mg. Short descriptor: "Hydroxyzine hcl injection".
How much does Medicare pay for J3410?
In 2024, the average Medicare payment was $8.78 per service (average allowed $11.81).
Does Medicare cover J3410?
Coverage code D — Special coverage instructions apply. Medicare covers it when its national or local coverage criteria are met.
How many units of J3410 can be billed per day?
16 on outpatient hospital claims; 8 on practitioner claims (NCCI medically unlikely edits).
Related J34 codes
- J3400 — Injection, triflupromazine hcl, up to 20 mg
- J3401 — Beremagene geperpavec-svdt for topical administration, containing nominal 5 x 10^9 pfu/ml vector genomes, per 0.1 ml
- J3402 — Injection, remestemcel-l-rknd, per therapeutic dose
- J3403 — Revakinagene taroretcel-lwey, per implant
- J3404 — Injection, zopapogene imadenovec-drba suspension, per therapeutic dose
- J3405 — Injection, onasemnogene abeparvovec-brve, per treatment
- J3406 — Injection, omidubicel-onlv, per therapeutic dose
- J3411 — Injection, thiamine hcl, 100 mg
- J3415 — Injection, pyridoxine hcl, 100 mg
- J3420 — Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg
- J3424 — Injection, hydroxocobalamin, intravenous, 25 mg
- J3425 — Injection, hydroxocobalamin, intramuscular, 10 mcg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J3410
- Watch J3410 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J3410
Sources: CMS HCPCS Level II release October 2026; CMS DMEPOS fee schedule; CMS NCCI MUE tables; CMS Medicare utilization (physician and DME supplier files); CMS Medicare Coverage Database articles. Fees are Medicare allowables, not commercial rates. Not billing or legal advice.